ClinicalTrials.gov
public full text
Public Domain
Registry of Patients Having Received oNKord®
ReKORD is an observational study (Registry) enrolling participants who have received at least one dose of oNKord® (allogeneic ex vivo-generated Natural Killer \[NK\] cells from CD34+ umbilical cord blood progenitor cells) in a clinical trial. Participants from multiple previous clinical trials of oNKord® can be enrolled in this Registry.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma#881209
- Sosialisasi Edukasi Sasaran Keselamatan Pasien (Patient Safety) Pada Perawat di Rumkit Tk. II Dr.Prof. J. A. Latumeten#1006441
- RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies#838986
- Increasing Knowledge and Interest in Cancer Clinical Trials#829331
- Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer#898059
Record · ID 811929
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive